Dipeptide transport in brush-border membrane vesicles (BBMV) prepared from human full-term placentae.

The uptakes of the tritiated, hydrolysis-resistant cationic (d-Phe-L-Lys), neutral (D-Phe-L-Ala) and anionic (D-Phe-L-Glu) peptides into human full-term placental brush-border membrane vesicles (BBMV) were time-dependent and into an osmotically-active space. Uptakes of D-Phe-L-Lys and D-Phe-L-Glu were temperature-dependent. Uptake of D-Phe-L-Lys was electroneutral (either cation exchange or anion co-transport), whereas D-Phe-L-Ala and D-Phe-L-Glu were both stimulated by an increasingly inside-positive membrane potential (explained by either cation exchange or anion co-transport, or translocation alone, respectively). Uptake of D-Phe-L-Ala was stimulated (approximately 50 per cent) by an inwardly-directed proton gradient (pHin = 7.4, pHout = 5.5), whereas D-Phe-L-Glu was unaffected, and D-Phe-L-Lys uptake was inhibited (approximately 50 per cent) but was unaffected by the organic cation-exchange inhibitors 1,1-diethyl-2,2-cyanine (decynium22) and 5-(N-methyl-N-isobutyl)amiloride (MIBA). Over the concentration range studies, the peptides did not self-inhibit, and the only cross-inhibition was by D-Phe-L-Glu on D-Phe-L-Lys uptake (estimated K(I) 24.2 +/- 1.36 mM), suggesting very low affinity transporter(s). Under conditions favouring its transport by PepT1, D-Phe-L-Glu uptake was unaffected by diethylpyrocarbonate (DEPC); neither D-Phe-L-Ala nor D-Phe-L-Lys was inhibited by DEPC under maximally proton-stimulated conditions of uptake. We conclude that Pep-T-like transporters are not responsible for peptide uptake into human placental BBMV; while the molecular identity of the transporter(s) involved remains unclear, we hypothesize that they could be similar to the as yet unidentified epithelial basolateral peptide transporter(s).

Effects of manipulating serotonin on the incidence of ovulation in the rat.

Previous studies have shown that while depletion of brain serotonin by the administration of p-chlorophenylalanine (PCPA), an inhibitor of tryptophan hydroxylase, blocks the daily surge of LH in oestrogen-treated ovariectomized rats, restoration of serotonin synthesis by treatment with its immediate precursor, 5-hydroxytryptophan (5-HTP), at a critical time of day, reinstates the surge. The present study indicates that the experimental procedure involving serotonin depletion and its subsequent replenishment may also be used to control the preovulatory LH surge and ovulation in intact cyclic rats provided that (1) the PCPA is administered subcutaneously rather than intraperitoneally nad (2) the 5-HTP is given in conjunction with carbidopa, a peripheral decarboxylase inhibitor: the latter observation providing further evidence for a central role for serotonin in the control of ovulation. These precautions were unnecessary when oestrogen was administered at the same time as the PCPA. It appears that PCPA administered intraperitoneally results in a suppression of the preovulatory rise in oestrogen secretion (and may have additional deleterious effects at the level of the ovaries) and that 5-HTP, in the absence of supplementary oestrogen, may block ovulation by peripheral action after conversion to serotonin. This study indicates the need for caution when using pharmacological 'cocktails' to investigate neuroendocrine events underlying ovulation when the experiments are carried out in the presence of the ovaries.